Bob Geho Diasome's guest appearances

Bob Geho Diasome

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Bob Geho

Bob Geho, CEO, Diasome discusses the current treatments for diabetes and the nearly 100 year history of insulin.  He talks about the company's hepatocyte directed vesicle (HDV) nanotechnology that can be added to any insulin to lessen the instances of high and low blood sugar levels in people with diabetes.  HDV nanotechnology can be added to any insulin to improve its safety and efficacy by targeting specific organs and in this case, restoring the liver's natural role in blood glucose control. #Type1Diabetes  #Type2Diabetes  #Diabetes #Insulin @diasome Diasome.com

Bob Geho, CEO, Diasome discusses the current treatments for diabetes and the nearly 100 year history of insulin.  He talks about the company's hepatocyte directed vesicle (HDV) nanotechnology that can be added to any insulin to lessen the instances of high and low blood sugar levels in people with diabetes.  HDV nanotechnology can be added to any insulin to improve its safety and efficacy by targeting specific organs and in this case, restoring the liver's natural role in blood glucose control. #Type1Diabetes  #Type2Diabetes  #Diabetes #Insulin @diasome <a href="http://diasome.com" rel="noopener nofollow" target="_blank">Diasome.com</a>

Developing Smarter Insulin to Treat Diabetes with Bob Geho Diasome